BBP-561

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameBBP-561
Drug Alias NameBBP-561
ClassificationSmall molecules
Mechanisms of ActionKallikreins inhibitors
TargetsKallikreins
Therapy Area/IndicationsIchthyosiform Erythroderma, Congenital
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBridgebio Pharma
China Registration ClassN/A

Develop Information

Active CompaniesBridgebio Pharma
Inactive CompaniesN/A
Active IndicationsIchthyosiform Erythroderma, Congenital
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A